SecBot SecBot
8-K ·Filed May 18, 2026

WH

WYNDHAM HOTELS & RESORTS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001140361-26-021771
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

This filing contains no material financial data or operational changes. The CEO's health disclosure and CAO departure are routine personnel events. Monitor upcoming quarterly earnings for any operational impact from the CEO's reduced travel, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$77.79
T+0 close · May 18, 2026 · via day close
Latest settled
−5.21%
T+60 · $73.74
Vs SPY
−9.79%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $77.79entry
  2. T+1 · 6mo ago −0.76%α −0.11% · $77.20
  3. T+5 · 6mo ago +3.41%α +1.79% · $80.44
  4. T+20 · 5mo ago +4.57%α +2.38% · $81.35
  5. T+60 · 3mo ago −5.21%α −9.79% · $73.74

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Geoff Ballotti disclosed a multiple myeloma diagnosis with a favorable prognosis, stating he will continue working largely as normal. Separately, CAO Nicola Rossi will depart on July 31, 2026, with internal successor Christopher Androski named. The 2026 annual meeting results were also filed, showing all director nominees elected and say-on-pay approved with ~85% support. Neither event provides material new financial information or changes the company's operational outlook.

Key Facts

  • CEO Geoff Ballotti diagnosed with multiple myeloma, a treatable form of bone cancer; prognosis is favorable and he plans to continue working largely as normal.
  • Chief Accounting Officer Nicola Rossi will depart on July 31, 2026; Christopher Androski (current SVP & Controller) will succeed him.
  • 2026 Annual Meeting held May 14, 2026: all 9 director nominees elected; say-on-pay approved with ~85% of votes cast in favor; auditor ratification passed with ~99% support; stockholder written consent proposal passed with ~63% support.
  • No financial figures, guidance changes, or material operational updates were disclosed in this filing.

Financial Impact

No financial impact disclosed. CEO health disclosure and CAO transition are personnel matters without quantifiable financial exposure.

Risk Factors

  • CEO's health condition could worsen despite favorable prognosis, potentially creating leadership uncertainty.
  • CAO transition may introduce minor accounting process risk during the handoff period.

Market Snapshot

Exchange
NYSE
Sector
Hotels & Motels
Analyst Consensus
84% bullish (25 analysts)

Investment Themes

Services

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-021771
Document: ef20073914_ex99-1.htm0001140361-26-021771
Document: 0001140361-26-021771-index-headers.html0001140361-26-021771
Document: 0001140361-26-021771-index.html0001140361-26-021771
Document: 0001140361-26-021771.txt0001140361-26-021771

US Market Status

Market Closed · Opens in 6h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026